Financials data is unavailable for this security.
View more
Year on year Kohjin Bio Co Ltd 's net income deteriorated -53.61% from 829.79m to 384.98m despite relatively flat revenues. A contributing factor has been the increase in the cost of goods sold, selling, general and administrative expenses and interest paid (all as a percent of sales).
| Gross margin | -- |
|---|---|
| Net profit margin | -- |
| Operating margin | -- |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in JPYView more
In 2024, Kohjin Bio Co Ltd increased its cash reserves by 18.08%, or 264.37m. The company earned 823.68m from its operations for a Cash Flow Margin of 17.27%. In addition the company used 577.35m on investing activities and also paid 1.35m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 1,003.21 |
|---|---|
| Tangible book value per share | 1,002.70 |
More ▼
Balance sheet in JPYView more
| Current ratio | 2.12 |
|---|---|
| Quick ratio | 1.82 |
| Total debt/total equity | 0.4168 |
|---|---|
| Total debt/total capital | 0.2942 |
More ▼
Growth rates in JPY
Year on year, growth in earnings per share excluding extraordinary items dropped -53.61%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -- |
